484 related articles for article (PubMed ID: 35133644)
21. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.
Sholler DJ; Huestis MA; Amendolara B; Vandrey R; Cooper ZD
Pharmacol Biochem Behav; 2020 Dec; 199():173059. PubMed ID: 33086126
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in
Oakes M; Law WJ; Komuniecki R
J Neurosci; 2019 May; 39(21):4142-4152. PubMed ID: 30886012
[No Abstract] [Full Text] [Related]
24. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid physiology and pharmacology: 30 years of progress.
Howlett AC; Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Porrino LJ
Neuropharmacology; 2004; 47 Suppl 1():345-58. PubMed ID: 15464149
[TBL] [Abstract][Full Text] [Related]
26. Terpenoids, Cannabimimetic Ligands, beyond the
Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
[TBL] [Abstract][Full Text] [Related]
27. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Krebs MO; Kebir O; Jay TM
Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
[TBL] [Abstract][Full Text] [Related]
28. Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.
Docampo-Palacios ML; Ramirez GA; Tesfatsion TT; Okhovat A; Pittiglio M; Ray KP; Cruces W
Molecules; 2023 Sep; 28(17):. PubMed ID: 37687263
[TBL] [Abstract][Full Text] [Related]
29. [Potential applications of marijuana and cannabinoids in medicine].
Zdrojewicz Z; Pypno D; Cabała K; Bugaj B; Waracki M
Pol Merkur Lekarski; 2014 Oct; 37(220):248-52. PubMed ID: 25518584
[TBL] [Abstract][Full Text] [Related]
30. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
31. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
32. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
[TBL] [Abstract][Full Text] [Related]
33. The evolution of cannabinoid receptors in cancer.
Pennant NM; Hinton CV
WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
35. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Darmani NA; Janoyan JJ; Crim J; Ramirez J
Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases.
Maselli DB; Camilleri M
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1748-1758.e2. PubMed ID: 32673642
[TBL] [Abstract][Full Text] [Related]
37. Clinical uses of cannabis and cannabinoids in the United States.
Levinsohn EA; Hill KP
J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
40. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
